Incyte (INCY) Cash from Operations (2010 - 2026)
Incyte (INCY) reported Cash from Operations of $507.66 million for Q2 2026, compared with $44.74 million a year earlier and up 37.4% from the prior quarter.
Powered by 
Analysis
Incyte (INCY) Cash from Operations (2010 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Incyte's Cash from Operations came in at $1.98 billion, up 97.4% year-over-year; for FY2025, it was $1.41 billion, up 321.5% from FY2024.
- By year, Cash from Operations came in at $335.34 million in FY2024 (-32.5%), $496.49 million in FY2023 (-48.8%), $969.94 million in FY2022 (+29.4%) and $749.49 million in FY2021.
- Five-year quarterly Cash from Operations spans a low of -$575.56 million in Q2 2024 and a high of $559.39 million in Q3 2025.
- The high point for year-over-year Cash from Operations in five years was Q4 2024 (growth of 158.1%); the low point was Q3 2023 (a decline of 50.1%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $369.35 million (Q1 2026), $543.3 million (Q4 2025) and $559.39 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 8.62 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 3.44 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 5.37 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 5.88 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 4.58 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 4.00 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 3.57 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 835.00 Mn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 1.13 Bn |
| 10 | Incyte | 24.39 Bn | 9.33 Bn | 1.57 Bn | 507.66 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 507.66 Mn |
| Mar 31, 2026 | 369.35 Mn |
| Dec 31, 2025 | 543.30 Mn |
| Sep 30, 2025 | 559.39 Mn |
| Jun 30, 2025 | 44.74 Mn |
| Mar 31, 2025 | 266.07 Mn |
| Dec 31, 2024 | 381.22 Mn |
| Sep 30, 2024 | 310.87 Mn |
| Jun 30, 2024 | -575.56 Mn |
| Mar 31, 2024 | 218.81 Mn |
| Dec 31, 2023 | 147.73 Mn |
| Sep 30, 2023 | 147.84 Mn |
| Jun 30, 2023 | 306.53 Mn |
| Mar 31, 2023 | -105.60 Mn |
| Dec 31, 2022 | 283.66 Mn |
| Sep 30, 2022 | 296.38 Mn |
| Jun 30, 2022 | 174.16 Mn |
| Mar 31, 2022 | 215.74 Mn |
| Dec 31, 2021 | 115.35 Mn |
| Sep 30, 2021 | 255.10 Mn |
API Access
Incyte Cash from Operations API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-from-operations&ticker=INCY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-from-operations", "ticker": "INCY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-from-operations&ticker=INCY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();